Top

Sleep and Breathing

Published in:

14-08-2021 | Sleep Apnea | Hypoxia • Original Article

Association between nocturnal hypoxemic burden and glucose metabolism

Authors: Sikawat Thanaviratananich, Hao Cheng, Naricha Chirakalwasan, Sirimon Reutrakul

Published in: Sleep and Breathing | Issue 3/2022

Abstract

Purpose

To evaluate the association between a novel integrated event-based and hypoxemia-based parameter of polysomnography (PSG), hypoxemic load or HL100, and fasting blood glucose (FBG) and hemoglobin A1c (HbA1c) levels.

Methods

Adult patients, who underwent an in-lab PSG at the University of Iowa Hospitals and Clinics with FBG or HbA1c levels, were included. Event-based parameter and hypoxemia-based parameter data were derived. HL100, defined as the integrated area of desaturation between the 100% oxygen saturation and the measured saturation levels during sleep divided by the total sleep time, was calculated by Python software. Demographic data and glycemic parameters within 1 year prior to PSG (FBG and HbA1c) were retrieved from chart review. Spearman correlation analysis and stepwise backward regression analysis were performed to determine independent predictors of FBG and HbA1c levels.

Results

Of the 467 patients who underwent an in-lab PSG, 218 had FBG levels, 84 had HbA1c levels, and 118 had both values. All event-based and hypoxemia-based parameters, including HL100, were significantly correlated to FBG and HbA1c levels. Stepwise backward regression analyses, adjusted for age, sex, body mass index, and diabetes status, revealed that log HL100 was significantly related to FBG (B = 23.9, p = 0.010), but none of log event-based or hypoxemia-based parameters were found to be significantly related HbA1c levels.

Conclusions

HL100 was shown to be an independent predictor of FBG in this cohort, implying that any degree of desaturation below 100% could adversely affect glucose metabolism. HL100 may be useful for interpretation of sleep studies, risk stratification, and patient management purposes in the future.

Heinzer R, Vat S, Marques-Vidal P, Marti-Soler H, Andries D, Tobback N, Mooser V, Preisig M, Malhotra A, Waeber G, Vollenweider P, Tafti M, Haba-Rubio J (2015) Prevalence of sleep-disordered breathing in the general population: the HypnoLaus study. Lancet Respir Med 3(4):310–318. https://doi.org/10.1016/S2213-2600(15)00043-0 CrossRefPubMedPubMedCentral

Linz D, Colling S, Nussstein W, Debl K, Hohl M, Fellner C, Bohm M, Maier LS, Hamer OW, Buchner S, Arzt M (2018) Nocturnal hypoxemic burden is associated with epicardial fat volume in patients with acute myocardial infarction. Sleep Breath = Schlaf Atmung 22(3):703–711. https://doi.org/10.1007/s11325-017-1616-0

Louis M, Punjabi NM (2009) Effects of acute intermittent hypoxia on glucose metabolism in awake healthy volunteers. J Appl Physiol (Bethesda, Md: 1985) 106(5):1538–1544. https://doi.org/10.1152/japplphysiol.91523.2008

Newhouse LP, Joyner MJ, Curry TB, Laurenti MC, Man CD, Cobelli C, Vella A, Limberg JK (2017) Three hours of intermittent hypoxia increases circulating glucose levels in healthy adults. Physiol Rep 5(1). https://doi.org/10.14814/phy2.13106

Oltmanns KM, Gehring H, Rudolf S, Schultes B, Rook S, Schweiger U, Born J, Fehm HL, Peters A (2004) Hypoxia causes glucose intolerance in humans. Am J Respir Crit Care Med 169(11):1231–1237. https://doi.org/10.1164/rccm.200308-1200OC CrossRefPubMed

Rafacho A, Goncalves-Neto LM, Ferreira FB, Protzek AO, Boschero AC, Nunes EA, Zoccal DB (2013) Glucose homoeostasis in rats exposed to acute intermittent hypoxia. Acta Physiol (Oxf) 209(1):77–89. https://doi.org/10.1111/apha.12118 CrossRef

Tamura A, Kawano Y, Watanabe T, Kadota J (2012) Obstructive sleep apnea increases hemoglobin A1c levels regardless of glucose tolerance status. Sleep Med 13(8):1050–1055. https://doi.org/10.1016/j.sleep.2012.04.007 CrossRefPubMed

Reutrakul S, Mokhlesi B (2017) Obstructive sleep apnea and diabetes: a state of the art review. Chest 152(5):1070–1086. https://doi.org/10.1016/j.chest.2017.05.009 CrossRefPubMedPubMedCentral

Rusu A, Bala CG, Craciun AE, Roman G (2017) HbA1c levels are associated with severity of hypoxemia and not with apnea hypopnea index in patients with type 2 diabetes: results from a cross-sectional study. J Diabetes 9(6):555–561. https://doi.org/10.1111/1753-0407.12452 CrossRefPubMed

10.

Torrella M, Castells I, Gimenez-Perez G, Recasens A, Miquel M, Simo O, Barbeta E, Sampol G (2015) Intermittent hypoxia is an independent marker of poorer glycaemic control in patients with uncontrolled type 2 diabetes. Diabetes Metab 41(4):312–318. https://doi.org/10.1016/j.diabet.2015.01.002 CrossRefPubMed

11.

Kapur VK, Resnick HE, Gottlieb DJ (2008) Sleep disordered breathing and hypertension: does self-reported sleepiness modify the association? Sleep 31(8):1127–1132 PubMedPubMedCentral

12.

Won CHJ (2020) When will we ditch the AHI? J Clin Sleep Med 16(7):1001–1003. https://doi.org/10.5664/jcsm.8594 CrossRefPubMedPubMedCentral

13.

Punjabi NM (2016) COUNTERPOINT: Is the apnea-hypopnea index the best way to quantify the severity of sleep-disordered breathing? No. Chest 149(1):16–19. https://doi.org/10.1378/chest.14-2261 CrossRefPubMed

14.

Aronsohn RS, Whitmore H, Van Cauter E, Tasali E (2010) Impact of untreated obstructive sleep apnea on glucose control in type 2 diabetes. Am J Respir Crit Care Med 181(5):507–513. https://doi.org/10.1164/rccm.200909-1423OC CrossRefPubMed

15.

Kosseifi S, Bailey B, Price R, Roy TM, Byrd RP Jr, Peiris AN (2010) The association between obstructive sleep apnea syndrome and microvascular complications in well-controlled diabetic patients. Mil Med 175(11):913–916. https://doi.org/10.7205/milmed-d-10-00131 CrossRefPubMed

16.

Lindberg E, Theorell-Haglöw J, Svensson M, Gislason T, Berne C, Janson C (2012) Sleep apnea and glucose metabolism: a long-term follow-up in a community-based sample. Chest 142(4):935–942. https://doi.org/10.1378/chest.11-1844 CrossRefPubMed

17.

Papanas N, Steiropoulos P, Nena E, Tzouvelekis A, Maltezos E, Trakada G, Bouros D (2009) HbA1c is associated with severity of obstructive sleep apnea hypopnea syndrome in nondiabetic men. Vasc Health Risk Manag 5:751–756. https://doi.org/10.2147/vhrm.s7057 CrossRefPubMedPubMedCentral

18.

Pillai A, Warren G, Gunathilake W, Idris I (2011) Effects of sleep apnea severity on glycemic control in patients with type 2 diabetes prior to continuous positive airway pressure treatment. Diabetes Technol Ther 13(9):945–949. https://doi.org/10.1089/dia.2011.0005 CrossRefPubMed

19.

Priou P, Le Vaillant M, Meslier N, Chollet S, Pigeanne T, Masson P, Bizieux-Thaminy A, Humeau MP, Goupil F, Ducluzeau PH, Gagnadoux F (2015) Association between obstructive sleep apnea severity and glucose control in patients with untreated versus treated diabetes. J Sleep Res 24(4):425–431. https://doi.org/10.1111/jsr.12278 CrossRefPubMed

20.

Sökücü SN, Karasulu L, Dalar L, Ozdemir C, Seyhan EC, Aydin S, Altin S (2013) Effect of hypoxia on glucose metabolism in nondiabetic patients with obstructive sleep apnea syndrome. Arch Bronconeumol 49(8):321–325. https://doi.org/10.1016/j.arbres.2013.01.006 CrossRefPubMed

21.

Stamatakis K, Sanders MH, Caffo B, Resnick HE, Gottlieb DJ, Mehra R, Punjabi NM (2008) Fasting glycemia in sleep disordered breathing: lowering the threshold on oxyhemoglobin desaturation. Sleep 31(7):1018–1024 PubMedPubMedCentral

22.

Azarbarzin A, Sands SA, Stone KL, Taranto-Montemurro L, Messineo L, Terrill PI, Ancoli-Israel S, Ensrud K, Purcell S, White DP, Redline S, Wellman A (2019) The hypoxic burden of sleep apnoea predicts cardiovascular disease-related mortality: the Osteoporotic Fractures in Men Study and the Sleep Heart Health Study. Eur Heart J 40(14):1149–1157. https://doi.org/10.1093/eurheartj/ehy624 CrossRefPubMed

23.

Wang N, Meng Z, Ding N, Chen W, Zhang X, Huang M, Xu J (2020) Oxygen desaturation rate as a novel intermittent hypoxemia parameter in severe obstructive sleep apnea is strongly associated with hypertension. J Clin Sleep Med 16(7):1055–1062. https://doi.org/10.5664/jcsm.8396 CrossRefPubMedPubMedCentral

24.

Narkiewicz K, van de Borne PJ, Montano N, Dyken ME, Phillips BG, Somers VK (1998) Contribution of tonic chemoreflex activation to sympathetic activity and blood pressure in patients with obstructive sleep apnea. Circulation 97(10):943–945. https://doi.org/10.1161/01.cir.97.10.943 CrossRefPubMed

25.

Fang Y, Zhang Q, Tan J, Li L, An X, Lei P (2014) Intermittent hypoxia-induced rat pancreatic β-cell apoptosis and protective effects of antioxidant intervention. Nutr Diabetes 4(9):e131. https://doi.org/10.1038/nutd.2014.28 CrossRefPubMedPubMedCentral

26.

Sherwani SI, Aldana C, Usmani S, Adin C, Kotha S, Khan M, Eubank T, Scherer PE, Parinandi N, Magalang UJ (2013) Intermittent hypoxia exacerbates pancreatic β-cell dysfunction in a mouse model of diabetes mellitus. Sleep 36(12):1849–1858. https://doi.org/10.5665/sleep.3214 CrossRefPubMedPubMedCentral

27.

Ciftci TU, Kokturk O, Bukan N, Bilgihan A (2004) The relationship between serum cytokine levels with obesity and obstructive sleep apnea syndrome. Cytokine 28(2):87–91. https://doi.org/10.1016/j.cyto.2004.07.003 CrossRefPubMed

28.

Nonogaki K (2000) New insights into sympathetic regulation of glucose and fat metabolism. Diabetologia 43(5):533–549. https://doi.org/10.1007/s001250051341 CrossRefPubMed

29.

Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS (1997) Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 389(6651):610–614. https://doi.org/10.1038/39335 CrossRefPubMed

30.

Ming H, Tian A, Liu B, Hu Y, Liu C, Chen R, Cheng L (2019) Inflammatory cytokines tumor necrosis factor-α, interleukin-8 and sleep monitoring in patients with obstructive sleep apnea syndrome. Exp Ther Med 17(3):1766–1770. https://doi.org/10.3892/etm.2018.7110 CrossRefPubMed

Title: Association between nocturnal hypoxemic burden and glucose metabolism
Authors: Sikawat Thanaviratananich
Hao Cheng
Naricha Chirakalwasan
Sirimon Reutrakul
Publication date: 14-08-2021
Publisher: Springer International Publishing
Keywords: Sleep Apnea
Hypoxemia
Polysomnography
Published in: Sleep and Breathing / Issue 3/2022
Print ISSN: 1520-9512
Electronic ISSN: 1522-1709
DOI: https://doi.org/10.1007/s11325-021-02464-3

Webinar | 08-11-2023 | 18:00 (CET)

Keynote Webinar | Spotlight on Diet and Diabetes

Watch now

An expert-led symposium exploring the prevention and management of type 2 diabetes through dietary interventions. Highlights include discussion of the recent EASD guidelines, therapeutic diets, food types and processing, plus psychological factors that influence patient success, and the drivers of healthy eating and diabetes control.

Prof. Mike Lean

Prof. Falko Sniehotta

Keynote Webinar | Spotlight on Diet and Diabetes

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 3/2022

Nasal function and CPAP use in patients with obstructive sleep apnoea: a systematic review

Position-dependent obstructive sleep apnea and its influence on treatment success of mandibular advancement devices

Sleep duration and risk of hyperlipidemia: a systematic review and meta-analysis of prospective studies

Evaluation of the corpus callosum shape in patients with obstructive sleep apnea

Is there a relationship between sleep apnoea and microalbuminuria?

Sleep-disordered breathing patterns in hospitalized patients with acute heart failure across the entire spectrum of ejection fraction

Keynote Webinar | Spotlight on Diet and Diabetes